Leveraging the Emergency Department (LEAD) Study
This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial. The study will first examine reach in a non-traditional setting (the Emergency Department - ED) that uses an Electronic Health Record (EHR)-embedded Social Determinants of Health (SDoH) screening tool to identify lung screening-eligible patients for a tailored intervention to increase lung screening uptake. Reach is defined as the absolute number, proportion, and representativeness of individuals targeted for lung screening knowledge, awareness, and uptake. Then, a pilot trial will be conducted to examine the preliminary effectiveness of a tailored lung screening intervention compared to enhanced usual care to influence individual-level potential drivers of lung screening (health literacy, mistrust, stigma, fatalism, knowledge, lung screening health beliefs) and the ability to increase lung screening uptake among screening-eligible patients. Quantitative (Randomized Controlled Trial and EHR data) methods will be used for data collection and analysis to address the study aims.
Checked against the public recordLast updated Feb 10, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Screening
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Hackensack Meridian Health
- Interventions being studied
- Behavioral: LungTalk; Other: Non-tailored lung screening
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Aged 50 years to 80 years * Currently smoke cigarettes or quit smoking cigarettes within the past 15 years * 20 pack-year smoking history * Has never had lung cancer screening * Able to provide informed consent * Able to speak and understand English Exclusion Criteria: * Diagnosed with lung cancer * Has a history of having a lung cancer screening scan * Unable to speak and understand English
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Ocean Medical CenterBrick, New Jersey
- John F. Kennedy Medical CenterEdison, New Jersey
- Hackensack University Medical CenterHackensack, New Jersey
- Bayshore Medical CenterHolmdel, New Jersey
- Southern Ocean Medical CenterManahawkin, New Jersey
- Jersey Shore University Medical CenterNeptune City, New Jersey
- Palisades Medical CenterNorth Bergen, New Jersey
- Old Bridge Medical CenterOld Bridge, New Jersey
- Raritan Bay Medical CenterPerth Amboy, New Jersey
- Riverview Medical CenterRed Bank, New Jersey
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 10, 2026. Always confirm current availability with the study team.